Ubiquilin 2 enhances osteosarcoma progression through resistance to hypoxic stress.

• Material Type: 博士論文
• ISSN: 1021-335X
• Title: Ubiquilin 2 enhances osteosarcoma progression through resistance to hypoxic stress.
• Volume: 33 4
• Author/Editor: Tsukamoto, Shinji; Shimada, Keiji; Honoki, Kanya; Kido, Akira; Akahane, Manabu; Tanaka, Yasuhito; Konishi, Noboru
• Author Heading: Tsukamoto, Shinji; Shimada, Keiji; Honoki, Kanya; Kido, Akira; Akahane, Manabu; Tanaka, Yasuhito; Konishi, Noboru
• Publication, Distribution, etc.: Spandidos
• Publication Date: 2015-04; 33 4
• Publication Date (W3CDTF): 2015-04
• Alternative Title: ユビキリン２は低酸素ストレスに耐性を示すことで骨肉腫の増殖を促進させる
• Periodical title: Oncology reports
• Degree grantor/type: 奈良県立医科大学
• Date Granted: 2015-05-28
• Date Granted (W3CDTF): 2015-05-28
• Dissertation Number: 甲第637号
• Degree Type: 博士（医学）
• Conferring No. (Dissertation): 甲第637号
• Text Language Code: eng
• Subject Heading: ubiquilin 2; osteosarcoma; hypoxia; HIF-1α; apoptosis
• Target Audience: 一般
• Note (General): type:Thesis; Ubiquilin 2 (UBQLN2), a member of the ubiquitin-like protein family (ubiquilins), maintains protein homeostasis. Although UBQLN2 has been implicated in the pathogenesis of neurodegenerative diseases, it is also associated with mali­gnant tumors. Therefore, we examined whether UBQLN2 plays a role in human osteosarcoma. The human osteosarcoma cell line MG63 was transfected with UBQLN2 siRNA and cultured under hypoxic conditions. The rat osteosarcoma cell line COS1NR was inoculated into Fischer 344 rats, followed by injection of UBQLN2 siRNA with atelocollagen. An immunohistochemical analysis of UBQLN2 was performed using 34 cases of human high-grade osteosarcomas, and metastasis-free survival was estimated by the Kaplan-Meier method. Silencing of UBQLN2 by siRNA transfection under hypoxia led to activation of JNK and p38, resulting in induction of apoptosis in the osteosarcoma cell line MG63. Injection of UBQLN2 siRNA suppressed tumor growth in the rat osteosarcoma model, followed by apoptosis induction. The immunohistochemical examination revealed that high UBQLN2 expression was significantly associated with the unfavorable metastasis-free survival of osteosarcoma patients. UBQLN2 plays an important role in resistance to hypoxic stress and enhances tumor progression in osteosarcoma. UBQLN2 may be a new molecular target for chemotherapeutics and a useful clinicopathological marker in human osteosarcoma.; 博士（医学）・甲第637号・平成27年5月28日; Copyright © Spandidos Publications 2015; 本文のリンク：http://dx.doi.org/10.3892/or.2015.3788; identifier:Oncology reports Vol.33 No.4 p.1799-1806(2015.04); identifier:1021335X; identifier:http://ginmu.naramed-u.ac.jp/dspace/handle/10564/3070; identifier:Oncology reports, 33(4): 1799-1806
• DOI: info:doi/10.3892/or.2015.3788; https://doi.org/info:doi/10.3892/or.2015.3788
• Persistent ID (NDL): info:ndljp/pid/10402588; https://dl.ndl.go.jp/pid/10402588
• Collection: 障害者向け資料
• Collection (Materials For Handicapped People:1): テキストデータ
• Collection (particular): 国立国会図書館デジタルコレクション > デジタル化資料 > 博士論文; https://dl.ndl.go.jp/collections/A00014
• Acquisition Basis: 博士論文（自動収集）
• Date Accepted (W3CDTF): 2017-08-02T04:31:34+09:00
• Format (IMT): application/pdf
• Access Restrictions: 国立国会図書館内限定公開
• Service for the Digitized Contents Transmission Service: 図書館・個人送信対象外
• Availability of remote photoduplication service: 可
• Periodical Title (URI): http://hdl.handle.net/10564/3070
• Data Provider (Database): 国立国会図書館 : 国立国会図書館デジタルコレクション; https://dl.ndl.go.jp

Table of Contents

2024-05-04 再収集

2024-05-04 再収集

2024-05-04 再収集